A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155] |
Wolchok, Jedd |
|
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192] |
Grisham, Rachel |
|
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006] |
Lendvai, Nikoletta |
|
A Phase IB Study of SGN-75 plus Everolimus in Patients with CD70-Positive Metastatic Renal Cell Cancer
[Protocol 12-263] |
Molina, Ana Maria |
|
A Phase IB Study of Vismodegib in Patients with Liver Cancer with Varying Degrees of Kidney and Liver Function
[Protocol 12-031] |
Abou-Alfa, Ghassan |
|
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma
[Protocol 10-084] |
Molina, Ana Maria |
|
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234] |
O'Reilly, Eileen |
|
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174] |
Gerecitano, John |
|
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170] |
Horwitz, Steven |
|
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056] |
Zelefsky, Michael |
|
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096] |
Chaft, Jamie |
- Lung Cancer, Non-Small Cell
|
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] |
Rimner, Andreas |
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
|
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Lymphoma
|
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266] |
Douer, Dan |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140] |
Traina, Tiffany |
|
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187] |
Scher, Howard |
- Prostate Cancer
- Rising PSA After Primary Therapy
|
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166] |
Janjigian, Yelena |
- Upper Gastrointestinal
- Esophageal Cancer
- Gastric Cancer
|
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076] |
Rampal, Raajit |
- Hematology
- Hematologic Disorders
- Hematologic Malignancies
- Leukemia
- Myeloproliferative Neoplasm
|
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257] |
Landau, Heather |
- Hematology
- Hematologic Disorders
- Hematologic Malignancies
|
